Interview study reveals men’s perception and concerns related to their prostate cancer journey.
Compared with patients who undergo surgery alone for abdominal or pelvic cancers, those who receive radiation and chemotherapy are at elevated risk for secondary sarcomas.
Efforts should be made to address patient concerns about clinical trial participation.
Among men on active surveillance or watchful waiting for low- and intermediate-risk prostate cancer (PCa), Blacks had a shorter median time from PCa diagnosis to definitive therapy compared with Whites.
A posttreatment program demonstrated that nurse practitioner-led follow-up visits can be an essential component of radiation therapy.